These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 1753671)

  • 1. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
    Steuhl KP; Rohrbach JM; Knorr M
    Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.
    Steuhl KP; Rohrbach JM; Knorr M; Thiel HJ
    Ophthalmology; 1993 Feb; 100(2):208-15. PubMed ID: 8437829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoclonal antibody HMB-45 in diagnosis of intra-ocular melanoma].
    Rohrbach JM; Steuhl KP; Thanos S
    Klin Monbl Augenheilkd; 1991 Oct; 199(4):274-7. PubMed ID: 1762354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical markers for cytoplasmic antigens in acquired melanosis, malignant melanomas, and nevi of the conjunctiva].
    Hitzer S; Bialasiewicz AA; Richard G
    Klin Monbl Augenheilkd; 1998 Oct; 213(4):230-7. PubMed ID: 9848068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of melanocytic lesions of the conjunctiva in a review of 10 675 ophthalmic specimens.
    Novais GA; Fernandes BF; Belfort RN; Castiglione E; Cheema DP; Burnier MN
    Int J Surg Pathol; 2010 Feb; 18(1):60-3. PubMed ID: 18611943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [S-100 protein in non-pigmented melanocytic and neuro-ectodermal tumors of the conjunctiva].
    Holbach L; Hofmann C
    Klin Monbl Augenheilkd; 1987 Feb; 190(2):105-8. PubMed ID: 3553717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent pigmented melanocytic nevus. A benign lesion, not to be mistaken for malignant melanoma.
    Sexton M; Sexton CW
    Arch Pathol Lab Med; 1991 Feb; 115(2):122-6. PubMed ID: 1992976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
    Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
    Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMB-45 immunohistochemical staining of conjunctival melanocytic lesions.
    McDonnell JM; Sun YY; Wagner D
    Ophthalmology; 1991 Apr; 98(4):453-8. PubMed ID: 1711186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMB-45 antibody reactivity in pigmented lesions of the conjunctiva.
    Glasgow BJ; McCall LC; Foos RY
    Am J Ophthalmol; 1990 Jun; 109(6):696-700. PubMed ID: 2189315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant blue nevus].
    Rupec R; Eckert F; Ruzicka T
    Hautarzt; 1993 Mar; 44(3):164-6. PubMed ID: 8463099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HMB 45 positive balloon cells in combined nevi].
    Laaff H; Kühnl-Petzoldt C
    Hautarzt; 1992 Sep; 43(9):566-8. PubMed ID: 1399602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reactivity of five different antibodies with benign and malignant melanocytic lesions].
    Plótár V; Szentirmay Z; Orosz Z
    Magy Onkol; 2008 Dec; 52(4):363-73. PubMed ID: 19068464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
    Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
    J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
    Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A
    Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
    Pluot M; Joundi A; Grosshans E
    Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.